Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Bullboard Posts
Comment by juniper88on Jun 23, 2020 9:37am
137 Views
Post# 31180142

RE:RE:The decoupling of the Covid cases vs deaths curve

RE:RE:The decoupling of the Covid cases vs deaths curveThere could be other explanations as well.  Like deaths will occur a few weeks after a rise in cases, so let's see what happens in the next couple of weeks.  Also, it seems doctors are using some medicines that will keep more patients alive.  And just because a person doesn't die doesn't mean they are not scarred for the rest of their life.

Btw, on a per capita basis the USA is now 26th in the world in testing (hardly # 1 as Trump would have you believe).  They are 9th in deaths per capita.

As for Trump, I don't believe this is simply about the economy.   


palinc2000 wrote: I also read that There is also an unproven theory by an Italian Doctor that the virus has mutated and not as deadly.
On the other hand the emphasis  by the  main media on the spike in the number of cases in some States  has a political implication ,,,,,,Dems need a very bad economy to beat Trump...
The Stock marke so far is takingeverything in stride and not panicking 


Wino115 wrote: This is NOT a political view, just interesting facts.  We've spoken a lot here on the current health environment and it's effect on global growth.  Here's an interesting free article that you don't typically see in the "hot" news on the interesting disconnect going on now between all these record high new cases, yet the seemingly constant decline in the death rate.  I'm a believer the death rate is what we should focus on and not cases since most people just stay home with a nasty flu for 2 weeks.  Not to minimize it, but we shouldn't gut the economy over that. They list 4 reasons. I am leaning toward the forth being a big reason why.  Anyway, this gives you good hope that we're past the worst and can get on with it, maybe a lot more safely (measured by deaths, not cases) than we all think. From the article: 

"Infections up 15 per cent in a fortnight, with 37,000 recorded in a day. For those who are inclined to see it that way, the graph of US COVID-19 cases is confirmation of the folly of reopening society far too soon.

But there is a little problem with this analysis: while the graph of cases in the US shows something which could be described as a second spike, the graph of deaths has stubbornly refused to follow suit. Quite the reverse: having peaked at over 2,000 deaths a day in April it is now down to around 600 a day and falling steadily.
How come? There are four possibilities – or possibly a combination of all four. Either more cases are being recorded, as a result of ramping-up of testing; the disease is becoming less virulent; we are getting better at treating it; or the disease has started infecting less vulnerable groups."





Bullboard Posts